Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211
Jessica Justman
, Timothy Skalland, Ayana Moore, Christopher I. Amos, Mark A. Marzinke, Sahar Z. Zangeneh, Colleen F. Kelley, Rebecca Singer, Stockton Mayer, Yael Hirsch-Moverman, Susanne Doblecki-Lewis, David Metzger, Elizabeth Barranco, Ken Ho, Ernesto T.A. Marques, Margaret Powers-Fletcher, Patricia J. Kissinger, Jason E. Farley, Carrie Knowlton, Magdalena E. Sobieszczyk, Shobha Swaminathan, Domonique Reed, Jean De Dieu Tapsoba, Lynda Emel, Ian Bell, Krista Yuhas, Leah Schrumpf, Laura Mkumba, Jontraye Davis, Jonathan Lucas, Estelle Piwowar-Manning, Shahnaz Ahmed, and
the CoVPN 5002 COMPASS Study Team
Author affiliations: Columbia University, New York, New York, USA (J. Justman, Y. Hirsch-Moverman, M.E. Sobieszczyk, D. Reed); Fred Hutchinson Cancer Center, Seattle, Washington, USA (T. Skalland, S.Z. Zangeneh, J. De Dieu Tapsoba, L. Emel, I. Bell, K. Yuhas); FHI 360, Durham, North Carolina, USA (A. Moore, L. Schrumpf, L. Mkumba, J. Davis, J. Lucas); Baylor College of Medicine, Houston, Texas, USA (C.I. Amos); Johns Hopkins University, Baltimore, Maryland, USA (M.A. Marzinke, J.E. Farley, E. Piwowar-Manning, S. Ahmed); Emory University, Atlanta, Georgia, USA (C.F. Kelley); University of Illinois Chicago, Chicago, Illinois, USA (R. Singer, S. Mayer); University of Miami, Miami, Florida, USA (S. Doblecki-Lewis); University of Pennsylvania, Philadelphia, Pennsylvania, USA (D. Metzger); Ponce Health Sciences University, Ponce, Puerto Rico (E. Barranco); University of Pittsburgh, Pittsburgh, Pennsylvania, USA (K. Ho, E.T.A. Marques); University of Cincinnati, Cincinnati, Ohio, USA (M. Powers-Fletcher); Tulane University, New Orleans, Louisiana, USA (P.J. Kissinger); University of Colorado, Aurora, Colorado, USA (C. Knowlton); Rutgers Medical School, Newark, New Jersey, USA (S. Swaminathan); RTI International, Research Triangle Park, North Carolina, USA (S.Z. Zangeneh)
Main Article
Figure 3
Figure 3. Prevalence of active or prior COVID-19 infection in 15 US communities, community cohort (n = 21,189), COMPASS 2021. A) By demographic characteristic across all sites. B) By age and site. Error bars indicate interquartile ranges. Note: Analysis of age limited to communities with >25 children who had complete data.
Main Article
Page created: January 10, 2024
Page updated: January 23, 2024
Page reviewed: January 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.